FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Werner Ebert

Research Profile

Disorders

Chemicals & Drugs

Anatomy

Concepts & Ideas

Neoplasm Staging

Co-author Network

Publications

TOP 3
Thomas Muley; Timea-Helene Fetz; Hendrik Dienemann; Hans Hoffmann; Felix Herth; Michael Meister; Werner Ebert
Tumor volume and tumor marker index based on CYFRA 21-1 and CEA are strong prognostic factors in operated early stage NSCLC.
Bernd Werle; Ulrike Schanzenbächer; Tamara T Lah; Eileen Ebert; Britta Jülke; Werner Ebert; Werner Fiehn; Klaus Kayser; Eberhard Spiess; Magnus Abrahamson; Janko Kos
Cystatins in non-small cell lung cancer: tissue levels, localization and relation to prognosis.
Bernd Werle; Matthias Kotzsch; Tamara T Lah; Janko Kos; D Gabrijelcic-Geiger; Eberhard Spiess; J Schirren; Werner Ebert; Werner Fiehn; Thomas Luther; V Magdolen; Manfred Schmitt; N Harbeck
Cathepsin B, plasminogenactivator-inhibitor (PAI-1) and plasminogenactivator-receptor (uPAR) are prognostic factors for patients with non-small cell lung cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Werner Ebert (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: Thomas Muley; Timea-Helene Fetz; Hendrik Dienemann; Hans Hoffmann; Felix Herth; Michael Meister; Werner Ebert
Tumor volume and tumor marker index based on CYFRA 21-1 and CEA are strong prognostic factors in operated early stage NSCLC.
Lung cancer (Amsterdam, Netherlands) 2008;60(3):408-15.
2006: Bernd Werle; Ulrike Schanzenbächer; Tamara T Lah; Eileen Ebert; Britta Jülke; Werner Ebert; Werner Fiehn; Klaus Kayser; Eberhard Spiess; Magnus Abrahamson; Janko Kos
Cystatins in non-small cell lung cancer: tissue levels, localization and relation to prognosis.
Oncology reports 2006;16(4):647-55.
2004: Bernd Werle; Matthias Kotzsch; Tamara T Lah; Janko Kos; D Gabrijelcic-Geiger; Eberhard Spiess; J Schirren; Werner Ebert; Werner Fiehn; Thomas Luther; V Magdolen; Manfred Schmitt; N Harbeck
Cathepsin B, plasminogenactivator-inhibitor (PAI-1) and plasminogenactivator-receptor (uPAR) are prognostic factors for patients with non-small cell lung cancer.
Anticancer research 2004;24(6):4147-61.
2004: Werner Ebert; Thomas Muley; K P Herb; Heinrich Schmidt-Gayk
Comparison of bone scintigraphy with bone markers in the diagnosis of bone metastasis in lung carcinoma patients.
Anticancer research 2004;24(5B):3193-201.
2004: Jean-Louis Pujol; Olivier Molinier; Werner Ebert; Jean-Pierre Daurès; Fabrice Barlesi; Gianfranco Buccheri; Marianne Paesmans; Elisabeth Quoix; denis moro-sibilot; M Szturmowicz; Jeanne-Marie Bréchot; Thomas Muley; J Grenier
CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer: results of a meta-analysis in 2063 patients.
British journal of cancer 2004;90(11):2097-105.
2004: Thomas Muley; Hendrik Dienemann; Werner Ebert
CYFRA 21-1 and CEA are independent prognostic factors in 153 operated stage I NSCLC patients.
Anticancer research 2004;24(3b):1953-6.
2003: Thomas Muley; Hendrik Dienemann; Werner Ebert
Increased CYFRA 21-1 and CEA levels are negative predictors of outcome in p-stage I NSCLC.
Anticancer research 2003;23(5b):4085-93.
2003: Bernd Werle; Kirsten Sauckel; Carl-Michael Nathanson; Maria Bjarnadottir; Eberhard Spiess; Werner Ebert; Magnus Abrahamson
Cystatins C, E/M and F in human pleural fluids of patients with neoplastic and inflammatory lung disorders.
Biological chemistry 2003;384(2):281-7.
2003: Thomas Muley; Werner Ebert; Petra Stieber; Hannelore Raith; Stefan Holdenrieder; Dorothea Nagel; Heinrich Fürst; Heinz-Jürgen Roth; Hilmar Luthe; Bert G Blijenberg; Eberhard Gurr; Wolfgang Uhl; Joachim von Pawel; Peter Drings
Technical performance and diagnostic utility of the new Elecsys neuron-specific enolase enzyme immunoassay.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2003;41(1):95-103.
2002: JR Fischer; P Baas; H D Becker; Lech Chyczewski; Hendrik Dienemann; Peter Drings; Werner Ebert; Felix Herth; H Hoffmann; Jerzy Laudanski; Harald Lahm; Ch Manegold; Mariano Monzó; W J Mooi; Thomas Muley; A Neuner; Jacek Niklinski; Wieslawa Niklinska; Rafael Rosell; Miquel Taron; L van't Veer; Bernd Werle; N v Zandwijk
Report from the first meeting of the 'European Network on Translational Research in Lung Cancer Amsterdam-Barcelona-Bialystok-Heidelberg'. Thoraxklinik Heidelberg, Germany, July 25, 2001.
Lung cancer (Amsterdam, Netherlands) 2002;36(2):221-4.
2002: Werner Ebert; Thomas Muley; Christine Trainer; Hendrik Dienemann; Peter Drings
Comparison of changes in the NSE levels with clinical assessment in the therapy monitoring of patients with SCLC.
Anticancer research 2002;22(2B):1083-9.
2000: Bernd Werle; C Kraft; Tamara T Lah; Janko Kos; Ulrike Schanzenbächer; Klaus Kayser; Werner Ebert; Eberhard Spiess
Cathepsin B in infiltrated lymph nodes is of prognostic significance for patients with nonsmall cell lung carcinoma.
Cancer 2000;89(11):2282-91.
2000: Ana Schweiger; A Staib; Bernd Werle; M Krasovec; Tamara T Lah; Werner Ebert; Vito Turk; Janko Kos
Cysteine proteinase cathepsin H in tumours and sera of lung cancer patients: relation to prognosis and cigarette smoking.
British journal of cancer 2000;82(4):782-8.
1999: Bernd Werle; A Staib; Britta Jülke; Werner Ebert; P Zladoidsky; Andreja Sekirnik; Janko Kos; Eberhard Spiess
Fluorometric microassays for the determination of cathepsin L and cathepsin S activities in tissue extracts.
Biological chemistry 1999;380(9):1109-16.
1999: Werner Ebert; Thomas Muley
CYFRA 21-1 in the follow-up of inoperable non-small cell lung cancer patients treated with chemotherapy.
Anticancer research 1999;19(4A):2669-72.
1997: Werner Ebert; M Hoppe; Thomas Muley; Peter Drings
Monitoring of therapy in inoperable lung cancer patients by measurement of CYFRA 21-1, TPA- TP CEA, and NSE.
Anticancer research 1997;17(4B):2875-8.
1997: E Ebert; Bernd Werle; Britta Jülke; Natasa Kopitar-Jerala; Janko Kos; Tamara T Lah; Magnus Abrahamson; Eberhard Spiess; Werner Ebert
Expression of cysteine protease inhibitors stefin A, stefin B, and cystatin C in human lung tumor tissue.
Advances in experimental medicine and biology 1997;421():259-65.
1997: Bernd Werle; Britta Jülke; Tamara T Lah; Eberhard Spiess; Werner Ebert
Cathepsin B fraction active at physiological pH of 7.5 is of prognostic significance in squamous cell carcinoma of human lung.
British journal of cancer 1997;75(8):1137-43.
1996: B Ulbricht; Wolfgang Hagmann; Werner Ebert; E Spiess
Differential secretion of cathepsins B and L from normal and tumor human lung cells stimulated by 12(S)-hydroxy-eicosatetraenoic acid.
Experimental cell research 1996;226(2):255-63.
1996: Werner Ebert; Thomas Muley; P Drings
Does the assessment of serum markers in patients with lung cancer aid in the clinical decision making process?
Anticancer research 1996;16(4B):2161-8.
1996: Werner Ebert; R Ryll; Thomas Muley; G Hug; P Drings
Do neuron-specific enolase levels discriminate between small-cell lung cancer and mediastinal tumors?
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1996;17(6):362-8.
1996: Bernd Werle; Werner Ebert; W Klein; E Spiess
Charge polymorphism in human lung cell pro-cathepsin B.
Anticancer research 1996;16(1):49-53.
1995: B Ulbricht; E Spiess; R Schwartz-Albiez; Werner Ebert
Quantification of intracellular cathepsin activities in human lung tumor cell lines by flow cytometry.
Biological chemistry Hoppe-Seyler 1995;376(7):407-14.
1995: Bernd Werle; Werner Ebert; W Klein; E Spiess
Assessment of cathepsin L activity by use of the inhibitor CA-074 compared to cathepsin B activity in human lung tumor tissue.
Biological chemistry Hoppe-Seyler 1995;376(3):157-64.
1994: G Probst; T Apfel; V Schulz; D Petzoldt; M Wiebel; Werner Ebert
[Diagnosis, therapy and prognosis of atypical mycobacterial infections--results of a retrospective study].
Pneumologie (Stuttgart, Germany) 1994;48(9):711-7.
1994: E Spiess; A Brüning; S Gack; B Ulbricht; Herbert Spring; G Trefz; Werner Ebert
Cathepsin B activity in human lung tumor cell lines: ultrastructural localization, pH sensitivity, and inhibitor status at the cellular level.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 1994;42(7):917-29.
1994: Werner Ebert; H Knoch; Bernd Werle; G Trefz; Thomas Muley; E Spiess
Prognostic value of increased lung tumor tissue cathepsin B.
Anticancer research 1994;14(3A):895-9.
1994: Bernd Werle; Werner Ebert; W Klein; E Spiess
Cathepsin B in tumors, normal tissue and isolated cells from the human lung.
Anticancer research 1994;14(3A):1169-76.
1994: Thomas Muley; M Wiebel; V Schulz; Werner Ebert
Elastinolytic activity of alveolar macrophages in smoking-associated pulmonary emphysema.
The Clinical investigator 1994;72(4):269-76.
1994: Werner Ebert; H Dienemann; A Fateh-Moghadam; M Scheulen; N Konietzko; T Schleich; E Bombardieri
Cytokeratin 19 fragment CYFRA 21-1 compared with carcinoembryonic antigen, squamous cell carcinoma antigen and neuron-specific enolase in lung cancer. Results of an international multicentre study.
European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies 1994;32(3):189-99.
1993: K Lüthgens; Werner Ebert; G Trefz; D Gabrijelcic; V Turk; Tamara T Lah
Cathepsin B and cysteine proteinase inhibitors in bronchoalveolar lavage fluid of lung cancer patients.
Cancer detection and prevention 1993;17(3):387-97.
1992: G Trefz; J Schliesser; B Heck; V Schulz; Werner Ebert
Alpha 1-proteinase inhibitor and mucus proteinase inhibitor in human lung emphysema.
The Clinical investigator 1992;70(3-4):269-76.
1992: M Erdel; E Spiess; G Trefz; H J Boxberger; Werner Ebert
Cell interactions and motility in human lung tumor cell lines HS-24 and SB-3 under the influence of extracellular matrix components and proteinase inhibitors.
Anticancer research 1992;12(2):349-59.
1991: G Trefz; B Streit; C W Justus; Werner Ebert; M D Kramer
Establishment of an enzyme-linked immuno-sorbent assay for urinary trypsin inhibitor by using a monoclonal antibody.
Journal of immunoassay 1991;12(3):347-69.
1990: Werner Ebert; H G Bauer; E Bauer; G Trefz
Significance of microbiological and biochemical analyses in empyema thoracis.
The Thoracic and cardiovascular surgeon 1990;38(6):348-51.
1990: M Erdel; W Peter; E Spiess; G Trefz; Werner Ebert
Karyotypic characterization of established cell lines derived from a squamous cell carcinoma and an adenocarcinoma of human lung cancers.
Cancer genetics and cytogenetics 1990;49(2):185-98.
1990: K Paul; B Heck; V Schulz; Werner Ebert; G Trefz; D Feist
[Clinical aspects, results of diagnostic pulmonary function tests and biochemical parameters in children with homozygote alpha-1-antitrypsin deficiency].
Pneumologie (Stuttgart, Germany) 1990;44(10):1217-9.
1990: B Leichtweis; Lieselotte Lennartz; Werner Ebert
Evaluation of the new IMx SCC test.
The Journal of nuclear medicine and allied sciences 1990;34(4 Suppl):309-13.
1990: M Erdel; G Trefz; E Spiess; S Habermaas; Herbert Spring; Tamara T Lah; Werner Ebert
Localization of cathepsin B in two human lung cancer cell lines.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 1990;38(9):1313-21.
1990: G Trefz; M Erdel; E Spiess; Werner Ebert
Detection of cathepsin B, plasminogen activators and plasminogen activator inhibitor in human non-small lung cancer cell lines.
Biological chemistry Hoppe-Seyler 1990;371(7):617-24.
1990: B Heck; Werner Ebert; V Schulz; G Trefz; K Paul
[Clinical aspects, diagnostic lung function and biochemical parameters in children with homozygous alpha 1-antitrypsin deficiency].
Pneumologie (Stuttgart, Germany) 1990;44 Suppl 1():418-9.
1990: Werner Ebert; G Trefz; B Heck; V Schulz
[Trypsin and pancreatic elastase-inhibitory capacity of serum and bronchoalveolar lavage fluid of smokers, ex-smokers and nonsmokers].
Pneumologie (Stuttgart, Germany) 1990;44 Suppl 1():267-8.
1989: G Trefz; B Heck; V Schulz; Werner Ebert
[Functional activity of the alpha1-proteinase inhibitor in serum and bronchoalveolar lavage fluid in congenital lung emphysema].
Pneumologie (Stuttgart, Germany) 1989;43(8):446-51.
1989: Werner Ebert; Heinrich Bülzebruck; H G Bauer
[The pathogen spectrum in acute and chronic pleural empyema].
Langenbecks Archiv für Chirurgie. Supplement II, Verhandlungen der Deutschen Gesellschaft für Chirurgie. Deutsche Gesellschaft für Chirurgie. Kongress 1989;():187-90.
1987: O L Schoenberger; S Beikirch; G Trefz; P Drings; Werner Ebert
Proteolytic activity of human tumor cell lines deriving from bronchial squamous cell carcinoma, pulmonary metastasis of rhabdomyosarcoma and pleural metastasis of mesothelioma.
European journal of respiratory diseases 1987;71(5):434-43.